Authors: Andrea Hofelich and Kimberly Westrich (National Pharmaceutical Council), Kevin Walker (Penn Quarter Partners), and Claudia Schur and Annelise Adams (Social & Scientific Systems, Inc.)
Publication: May 2014
Download the report.
The National Pharmaceutical Council’s (NPC) fourth annual survey of health care stakeholders is continuing to shed light on the current environment for comparative effectiveness research (CER) and health care decision-making.
Much of the ultimate importance of CER is tied to the way in which it is perceived and accepted by key health care stakeholders. NPC's booklet, “2014 Comparative Effectiveness Research and the Environment for Health Care Decision-Making,” provides important guidance into how those perceptions are changing as CER becomes more prevalent, especially with the Patient-Centered Outcomes Research Institute (PCORI) funding millions of dollars to conduct this research. The results of our survey show the state of play and evolution of stakeholder attitudes, assessing how key players in the health care ecosystem are viewing CER and judging its potential to change health care delivery.
By continuing this survey, NPC has been able to track changes in which organizations are perceived as influential in areas such as prioritizing, funding, conducting and monitoring CER, as well as assess the status of other issues affecting the current health care environment. This year, new questions were added that reflect growing trends and discussions among health care stakeholders, such as the use of real-world evidence, transparency in the processes for how evidence is interpreted and the integration of purchasing health care services. Highlights from this year’s survey indicate that:
- CER remains important to stakeholders;
- The full impact of CER on health care decision-making is still on the horizon; and
- PCORI is consistently considered a key player in the areas of prioritizing, funding and disseminating research.
Working with Social & Scientific Systems, Inc., we sent surveys to 435 individuals and organizational stakeholders on September 13, 2013, collecting responses through January 31, 2014. These stakeholders included reseachers/thought leaders; government; insurers/health plans; employers; business coalitions; and associations. In all, 110 complete responses were received.